Skip to main content
Clinical Trials/NCT06607250
NCT06607250
Completed
Not Applicable

Prospective Study on Biparametric MRI-based Multi-planar VI-RADS for Assessing Muscle Invasion in Bladder Cancer

The First Affiliated Hospital with Nanjing Medical University1 site in 1 country95 target enrollmentFebruary 20, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bladder (Urothelial, Transitional Cell) Cancer
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Enrollment
95
Locations
1
Primary Endpoint
VI-RADS score
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study is a prospective, single-center, observational clinical trial, enrolling 100 patients with malignant bladder tumors admitted to the Department of Urology at the People's Hospital of Jiangsu Province for treatment with transurethral resection or radical cystectomy.

All enrolled patients underwent multiparametric magnetic resonance imaging, including T2-weighted imaging (T2WI) in coronal, sagittal, and axial planes and diffusion-weighted imaging (DWI) in the same planes. The Vascular Invasion- and Invasion into the Detrusor muscle Assessment and Reporting System (VI-RADS) scores were evaluated for the enrolled patients. Diagnostic thresholds for muscle-invasive bladder cancer (MIBC) were set at VI-RADS scores ≥3 and ≥4, respectively. Descriptive statistics including sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated and compared against the surgical pathology gold standard results.

This study preliminarily validates the diagnostic performance of the 3D magnetic resonance-derived VI-RADS score in the assessment of muscle-invasive bladder cancer.

Registry
clinicaltrials.gov
Start Date
February 20, 2023
End Date
February 1, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

VI-RADS score

Time Frame: Immediately after enrollment

All enrolled patients underwent multiparametric MRI, which included T2WI (coronal, sagittal, axial planes) and diffusion-weighted imaging (DWI) in the coronal, sagittal, and axial planes to evaluate the VI-RADS score. A VI-RADS score of ≥3 and ≥4 were used as cutoff values for the diagnosis of MIBC.

Secondary Outcomes

  • statistical analysis(1 day)
  • positive predictive value (PPV), negative predictive value (NPV)(1 day)
  • the Receiver Operating Characteristic (ROC) curve(1 day)

Study Sites (1)

Loading locations...

Similar Trials